We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Recombinant Lysozyme Derived From Plants

By Biotechdaily staff writers
Posted on 13 Mar 2006
A recombinant human lysozyme has been produced in an animal-free system. More...
The bacterial-cell lysis agent can be used in diagnostic applications, bioprocessing, and life science research.

The lysozyme has many advantages over other lysing agents. Because it is produced in an animal-free system, it is free of infectious viral or prion contaminants. Prions are the causative agent of bovine spongiform encephalopathy (BSE), or mad cow disease. The lysozyme outperforms chicken lysozyme, a common animal-derived cell lysis agent, and is four times more active per mg for lysing Micrococcus and E coli. Lysobac, the lysozyme produced by Ventria Bioscience (Sacramento, CA, USA), is available in packages of 100 million, 10 billion, and 100 billion.

Lysobac is a recombinant protein that provides consistent cell lysis results so that process changes are minimized. For bioprocessing applications, it saves time by eliminating steps in the production process because it enables in-culture protein extraction. In addition, Lysobac is highly active and therefore it adds minimal volume to the final extract. It is cheaper than chicken lysozyme because of its high activity and efficient production methods. Lysobac is a gentle lysing agent providing minimal risk of denaturing the protein product.



Related Links:
Ventria

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Nutating Mixer
Enduro MiniMix
New
Gold Member
Latex Test
SLE-Latex Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.